STAT

DECEMBER 3, 2024

Swedish pharmaceutical company Orexo will no longer pursue an app for treating depression after many years of struggling to sell it. Orexo announced this week that it will no longer license the product, called Deprexis, from German manufacturer GAIA.

Pharmaceutical Companies 300

Pharmaceutical Companies Pharmaceutical Companies 300

STAT

DECEMBER 19, 2024

Access to cheaper alternatives and low enrollment prompted the company to remove the medicine — along with the HIV medicines Emtriva, Tybost, and Complera — from its patent assistance program next month, according to an Oct. 8 letter that announced the move and that has not been widely reported.

Pharmaceutical Companies 332

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Drug Development 332

STAT

FEBRUARY 14, 2025

Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. A member of the U.K. And the move comes after Moderna was chastised for the second time in five months by a U.K.

Vaccines 291

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 291

STAT

DECEMBER 6, 2024

The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer.

Pharmaceutical Companies 288

Pharmaceutical Companies Pharmaceutical Companies Drug Development 288

STAT

MARCH 17, 2025

In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.

Biosimilars 224

Biosimilars Hospitals Pharmaceutical Companies Pharmaceutical Companies 224

STAT

FEBRUARY 27, 2025

The public and pharmaceutical companies are calling for changes in drug regulation and the costs of medicines. Companies want to see products approved faster for financial reasons, and patients want medicines that can improve their lives. They are right to do so.

Pharmaceutical Companies 291

Pharmaceutical Companies Pharmaceutical Companies 291

STAT

MARCH 20, 2025

And reminiscent of a modern-day gold rush, there is now a headlong race among a growing number of pharmaceutical companies to determine how many other maladies the drugs may be capable of treating.

Diabetes 191

Diabetes Pharmaceutical Companies Pharmaceutical Companies 191

Drug Patent Watch

JANUARY 8, 2025

Drug patents are a form of intellectual property protection that grants pharmaceutical companies exclusive rights to manufacture, sell, and profit from their innovations for a set period. This exclusivity is the lifeblood of the industry, allowing companies to recoup their substantial R&D investments and fund future discoveries.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Documentation 52

STAT

DECEMBER 5, 2023

And pharmaceutical companies that learned of the vaccine-making power of the messenger RNA platform during the Covid-19 pandemic need new markets for their technology. Here are two things that are true. The world needs more effective flu vaccines. Read the rest…

Vaccines 363

Vaccines Pharmaceutical Companies Pharmaceutical Companies 363

STAT

MAY 31, 2024

The vested interests of pharmaceutical companies, lobbying groups, and conservative British broadcaster Nigel Farage bleating about “defending sovereignty” are threatening to derail the treaty process entirely. The treaty has been beset by delay and misinformation.

Pharmaceutical Companies 342

Pharmaceutical Companies Pharmaceutical Companies 342

STAT

JULY 11, 2024

Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief? STAT’s West Coast biotech reporter Jonathan Wosen joins “The Readout LOUD” to discuss what’s driving workforce cuts.    Read the rest…

Pharmaceutical Companies 322

Pharmaceutical Companies Pharmaceutical Companies Diabetes 322

STAT

AUGUST 8, 2024

Discovering a new drug is a big win for a pharmaceutical company, but selling it for lots of money with no competition? This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. The cherry on top. Read the rest…

Drug Pricing 325

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 325

STAT

DECEMBER 5, 2023

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the decision.

Pharmaceutical Companies 363

Pharmaceutical Companies Pharmaceutical Companies 363

STAT

NOVEMBER 22, 2022

The one-time treatment, called Hemgenix, was developed by the Dutch biotech company UniQure and will be marketed by CSL Behring, an Australian pharmaceutical company. The Food and Drug Administration on Tuesday approved the first gene therapy to treat people with hemophilia B, an inherited bleeding disorder.

Pharmaceutical Companies 342

Pharmaceutical Companies Pharmaceutical Companies 342

STAT

SEPTEMBER 19, 2024

Read the rest…

Pharmaceutical Companies 363

Pharmaceutical Companies Pharmaceutical Companies Hospitals 363

STAT

FEBRUARY 15, 2024

For several years , some of the world’s largest pharmaceutical companies that participate in a U.S. drug discount program overcharged the federal government and numerous hospitals by hundreds of millions of dollars, according to claims made in a recently unsealed lawsuit. and their number has grown over the years.

Hospitals 335

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 335

STAT

MARCH 21, 2024

But even as she expressed enthusiasm for the new drugs’ potential, Volkow criticized pharmaceutical companies for neglecting a moral imperative to develop new addiction treatments — but acknowledged that the health system more broadly doesn’t incentivize drug companies to treat the U.S.

Pharmaceutical Companies 361

Pharmaceutical Companies Pharmaceutical Companies Drug Development 361

STAT

DECEMBER 21, 2023

To ring the register, a pharmaceutical company may create a patent thicket , which involves filing dozens of patents that, in some cases, add little value to their medicines but extend precious monopolies. As a result, a drug company can quickly add a number of patents that can be used to protect its medicines from would-be rivals.

Biosimilars 332

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 332

STAT

JULY 2, 2024

These medications don’t have to be so expensive, but all too often pharmaceutical companies use illegal tactics to block competition that could lower prices and encourage innovation. Americans are facing an affordability crisis at the hands of corporate titans. Read the rest…

Pharmaceutical Companies 363

Pharmaceutical Companies Pharmaceutical Companies Drug Development 363

STAT

SEPTEMBER 30, 2024

The heads of pharmaceutical companies and medical device firms continued to sit at the top as their patented products reaped the biggest windfalls.  Those figures compared to an average of $13 million and median of $4.3 million in 2022.   Continue to STAT+ to read the full story…

Pharmaceutical Companies 363

Pharmaceutical Companies Pharmaceutical Companies Hospitals 363

STAT

MARCH 9, 2023

Oz is well-known for spreading medical misinformation , including touting astrology as a legitimate medical tool and the myth that apple juice contains unsafe levels of arsenic — a surprising political ally for Bourla, who runs one of the largest pharmaceutical companies in the world. Read the rest…

Pharmaceutical Companies 354

Pharmaceutical Companies Pharmaceutical Companies 354

STAT

NOVEMBER 19, 2024

Although more pharmaceutical companies are tailoring their business models to focus on low-income countries, overall industry efforts remain limited and patient access continues to suffer as a result , STAT writes, citing a new analysis.

Biosimilars 288

Biosimilars Immunization Immunity Pharmaceutical Companies 288

Drug Patent Watch

NOVEMBER 11, 2024

Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

STAT

AUGUST 12, 2024

Instead, it has allowed these drugs to continue to be prescribed and distributed for at least a year as the pharmaceutical companies retest them for equivalency to the original brand-name drugs.

Pharmaceutical Companies 357

Pharmaceutical Companies Pharmaceutical Companies 357

STAT

JULY 22, 2024

Notably, nearly half of the overcharges stemmed from drug rebates that Express Scripts negotiated with pharmaceutical companies.

Pharmaceutical Companies 363

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 363

STAT

OCTOBER 4, 2022

The press release issued by pharmaceutical companies Eisai and Biogen on Sept. 27 might someday be remembered as the beginning of a revolution in Alzheimer’s diagnosis and treatment.

Pharmaceutical Companies 325

Pharmaceutical Companies Pharmaceutical Companies Drug Development 325

STAT

MARCH 29, 2023

As the health impacts of climate change become harder to ignore, biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business.

Pharmaceutical Companies 276

Pharmaceutical Companies Pharmaceutical Companies 276

STAT

APRIL 30, 2024

Eli Lilly raised its full-year guidance on Tuesday while it reported strong first-quarter sales of Zepbound, even as the pharmaceutical company struggles to make enough of the obesity drug to meet the enormous demand. Lilly increased its adjusted earnings guidance for 2024 to a range of $13.50 per share.

Pharmaceutical Companies 332

Pharmaceutical Companies Pharmaceutical Companies 332

STAT

FEBRUARY 6, 2024

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

Diabetes 363

Diabetes Pharmaceutical Companies Pharmaceutical Companies 363

PharmaVoice

OCTOBER 17, 2024

The results provide the first clinical evidence of RNA editing, a burgeoning field that's drawn interest from biotechs and pharmaceutical companies alike.

Pharmaceutical Companies 246

Pharmaceutical Companies Pharmaceutical Companies 246

STAT

SEPTEMBER 9, 2024

Rather, I think the story offers valuable lessons on drug development for pharmaceutical companies, researchers, and the general public alike. To be clear, I’m not writing this to claim credit for discovery or development of GLP-1s or anything like that. Read the rest…

Drug Development 355

Drug Development Pharmaceutical Companies Pharmaceutical Companies 355

STAT

MAY 22, 2024

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company. The firm also said that it would be raising $500 million through a stock sale. 

Pharmaceutical Companies 318

Pharmaceutical Companies Pharmaceutical Companies 318

STAT

SEPTEMBER 26, 2024

Biden administration officials have abandoned their own proposal to require drug companies to disclose the prices and research costs of drugs that are driving up spending in state Medicaid programs.

Drug Pricing 351

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 351

STAT

NOVEMBER 1, 2023

He also has a track record at pharmaceutical companies like Novartis and Baxalta. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz.

Pharmaceutical Companies 347

Pharmaceutical Companies Pharmaceutical Companies 347

STAT

AUGUST 19, 2024

. The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments. 

Medical Schools 362

Medical Schools Drug Development Pharmaceutical Companies Pharmaceutical Companies 362

Drug Patent Watch

MARCH 5, 2025

But what drives this complex system, and how do pharmaceutical companies ensure that their drug names meet the strict guidelines set by regulatory agencies? At the heart of pharmaceutical drug naming is the International Nonproprietary Name (INN) system.

Pharmaceutical Companies 87

Pharmaceutical Companies Pharmaceutical Companies Dosage Labelling 87

STAT

SEPTEMBER 24, 2024

In the latest slap at a pharmaceutical company by a local government, the city of Baltimore has filed a lawsuit accusing Biogen of striking an “unlawful” scheme with the largest pharmacy benefit managers to block generic competition of a best-selling multiple sclerosis treatment.

Pharmaceutical Companies 361

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 361